Plain-English translation of NCT07100457 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research looks at a specific marker called OR6A2 found on certain immune cells in your blood, and how it relates to inflammation and heart damage after you've had emergency treatment to reopen a blocked heart artery. The study will collect blood samples from about 200 patients and track their health for about 3.5 years to see if this marker can predict who might have future heart problems.
When doctors reopen a blocked heart artery to treat a heart attack, sometimes the heart tissue is damaged by the sudden rush of blood flow — this is called reperfusion injury. Doctors want to find blood tests that can identify patients at highest risk for future heart complications, so they can provide better personalized care and monitoring.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn once or a few times to measure the markers being studied. Then you will be contacted or monitored for about 44 months (roughly 3.5 years) to track your health and any heart-related events. The study team will review your medical records and may contact you periodically to check on your condition.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
China